Key Updates
Boeing shares have advanced a further 2.38% to $237.52 since the August 3 report at $232.00, extending the cumulative 5-day gain to 7.20% and pushing YTD performance to +9.40%. The latest leg higher is underpinned by three incremental developments: confirmation of Q2 free cash flow turning positive at $0.6 billion, Morningstar's upward revision of its fair value estimate to $246 per share, and Boeing's decisive win over Airbus at Farnborough with 173 orders versus 154. The investment thesis of an operational turnaround in progress remains intact, with price now approaching the Morningstar fair value ceiling, narrowing the near-term upside buffer.
Current Trend
BA has established a clear short-term uptrend since the Q2 earnings release on July 28, recovering from a 6-month gain of only 0.67% to a YTD gain of 9.40% as of August 4. The 5-day momentum (+7.20%) reflects a compressed re-rating event driven by earnings, Farnborough order flow, and improving delivery metrics. Key observations:
- The stock has staged a sustained move from approximately $220 pre-earnings to $237.52, a range that now sits within 3.6% of Morningstar's revised $246 fair value estimate.
- The 6-month return of +0.67% confirms that the bulk of YTD gains are concentrated in the post-Q2 earnings window, indicating sentiment-driven re-rating rather than a prolonged structural recovery.
- Since the last report, price has continued to grind higher without a meaningful pullback, suggesting sustained buy-side interest but also limited near-term catalyst density ahead.
Investment Thesis
The core thesis centers on Boeing's multi-year operational and financial turnaround under CEO Kelly Ortberg, supported by: (1) a record $715 billion backlog providing long-duration revenue visibility; (2) a production ramp from 42 to 47 737 units per month with a target of 52+ via the new Everett facility; (3) pending certification of the 737 MAX-7, MAX-10, and 777X unlocking incremental delivery and cash flow streams; and (4) Global Services generating a stable 18.1% operating margin as a cash flow anchor. The thesis requires continued execution on production rates, FAA certification timelines, and defense segment stabilization — all of which remain works-in-progress. Management's own guidance of "a couple more years" before financial normalization sets a realistic but extended recovery horizon.
Thesis Status
The thesis is advancing on schedule but has not yet been validated by sustained profitability. Positive developments since the prior report include the first positive free cash flow quarter ($0.6 billion), record backlog, and Farnborough order momentum. However, the commercial segment operating margin remains negative at (2.7)%, the company posted a GAAP loss per share of ($0.67) in Q2, and the defense unit absorbed a $280 million Air Force One charge. Morningstar's fair value revision to $246 implies the market is beginning to price in turnaround success, compressing the margin of safety. The thesis remains constructive but the risk/reward profile is less asymmetric than it was at lower price levels.
Key Drivers
The following factors are driving near-term price action and medium-term investment outlook:
- Q2 Earnings — Positive FCF Inflection: Boeing generated $1.4 billion in operating cash flow and $0.6 billion in free cash flow in Q2 2026, a critical milestone for a company that has burned significant cash in prior years. Revenue of $24.6 billion was driven by 171 commercial deliveries. PR Newswire
- Farnborough Airshow — Order Supremacy: Boeing secured 173 aircraft orders at Farnborough, surpassing Airbus's 154 deals and marking its first major airshow win in four years. Key orders included 100 planes from SMBC Aviation and 28 787s for Riyadh Air. Business Insider
- Production Ramp and Quality Improvements: 737 Max production is expanding to a second Everett factory, targeting output of 52+ units per month. Defect-related labor time on the 737 line has fallen ~20% and fuselage defects by 40%. The New York Times
- Certification Pipeline: FAA certification of the 737 MAX-7, MAX-10, and 777X is expected in late 2026, which management projects will support approximately $1.5 billion in FCF for the full year and a path to $10+ billion by 2028. Morningstar
- New Aircraft Program Deferred: CEO Ortberg confirmed Boeing will not commit to a new narrowbody program for "a couple more years," focusing capital and management bandwidth on stabilizing existing programs. CNBC
Technical Analysis
BA is trading at $237.52, up 2.38% from the prior report level of $232.00. The stock has maintained upward momentum across all near-term timeframes (1d: +1.73%, 5d: +7.20%, 1m: +4.87%). The current price sits approximately 3.6% below Morningstar's revised fair value of $246, which now represents a near-term technical ceiling and analyst-derived resistance. The 6-month return of +0.67% confirms that $220–$225 acted as a base, with the post-earnings breakout establishing a new higher range. Immediate support is likely in the $226–$232 zone, corresponding to the post-earnings gap level. The absence of a meaningful consolidation following the 7.20% 5-day surge warrants monitoring for a potential short-term pullback toward this support band. No technical reversal signals are evident in the provided data, but the pace of the advance suggests the easy gains from the earnings re-rating may be largely captured at current levels.
Bull Case
- 1. Record $715 Billion Backlog Provides Unmatched Revenue Visibility: Boeing's total backlog reached a record $715 billion in Q2 2026, including over 6,200 commercial airplanes valued at $597 billion. This multi-year order book insulates the company from near-term demand shocks and underpins long-duration revenue generation. PR Newswire
- 2. Free Cash Flow Turned Positive — Path to $10B+ FCF by 2028: Q2 FCF of $0.6 billion marks a pivotal inflection. Management targets ~$1.5 billion FCF for full-year 2026 and a trajectory exceeding $10 billion by 2028, driven by production ramp and certification milestones. Morningstar raised its fair value to $246 on this basis. Morningstar
- 3. Farnborough Win Signals Restored Airline Confidence: Boeing outpaced Airbus at Farnborough with 173 vs. 154 orders — its first major airshow victory in four years. Orders from SMBC Aviation (100 planes) and Riyadh Air (28 x 787-9) demonstrate broad customer base support across lessor and airline segments. Business Insider
- 4. Production Ramp and Quality Gains Reducing Cost Drag: 737 Max production is scaling toward 52+ units per month via a second Everett facility, with defect-related labor time down ~20% and fuselage defects down 40%. H1 2026 deliveries of 314 jets represent the best first-half performance since 2018. The New York Times
- 5. Certification of 777X and 737 MAX Variants Unlocks New Revenue Streams: FAA certification of the 737 MAX-7, MAX-10, and 777X is expected in late 2026, with deliveries beginning in 2027. These programs will expand deliverable product mix and support margin recovery in the commercial segment. Morningstar
Bear Case
- 1. Commercial Segment Remains Unprofitable — Negative Operating Margin: Despite revenue of $11.8 billion in Q2, the Commercial Airplanes segment posted an operating margin of (2.7)%, and the company reported a GAAP loss per share of ($0.67). Consistent profitability in the core business remains elusive near-term. PR Newswire
- 2. Defense Segment Absorbing Recurring Charges — Air Force One Overhang: The defense unit posted a $280 million charge related to the Air Force One replacement program in Q2, contributing to a $15 million segment loss despite 13% revenue growth. Continued fixed-price contract exposure in defense represents a persistent earnings risk. Business Insider
- 3. CEO Acknowledges Multi-Year Financial Recovery Horizon: CEO Ortberg explicitly stated the company needs "a couple more years" to repair its finances before committing to a new aircraft program. This admission signals that normalized financial performance remains a 2028+ event, limiting near-term re-rating potential. CNBC
- 4. $1 Billion Everett Expansion Investment Pressures Near-Term FCF: The capital expenditure required for the second 737 production facility in Everett is approximately $1 billion, which will weigh on free cash flow generation in the near term even as it supports longer-term output targets. The New York Times
- 5. 777X Delivery Risk — Key Customer Rejecting Initial Units: Emirates President Tim Clark stated the airline would reject the first 10 delayed 777X jets expected in 2027, introducing execution risk around one of Boeing's most significant new program deliveries and potentially deferring associated cash receipts. Business Insider